Friday Feb 28
CHMP Issues Positive Opinion for Tablet Formulation of Mercka s NOXAFIL
The CHMP positive opinion will be reviewed by the European Commission, which if approved, grants a centralized marketing authorization with unified labeling that is valid in the 28 countries that are members of the European Union, as well as European Economic Area members Iceland, Liechtenstein and Norway.
Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
The New England journal of medicine In New England Journal of Medicine, Vol. 365, No.
Still seeking cure for Kimba
Since I started writing about Kimba nearly two years ago, he has acquired a devoted following.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Patent Issued for Methods of Providing Therapeutic Effects Using Cyclosporin Components
More particularly, the invention relates to methods including administering to an eye of a human or animal a therapeutically effective amount of a cyclosporin component to provide a desired therapeutic effect, preferably a desired ophthalmic or ocular therapeutic effect.